byetta glp-1 pharmaceuticals company overview Market Overview: Agonists and the Obesity Market | Blog BYETTA® Prescribing Information | AZ
Description
This Best Practice Guide has been created by an independent Multi-Disciplinary Team
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
These usually improve after a few days or weeks as the body adjusts
See how GLP-1s are reshaping diabetes & obesity care.
Separate fact from fiction regarding GLP-1 injections for weight loss
